“Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks”, Can Oncol Today, vol. 2, no. 3, pp. 22–28, Nov. 2025, doi: 10.58931/cot.2025.2342.